Discontinuation report CANCIDAS
| Report ID | 273087 |
| Drug Identification Number | 02244266 |
| Brand name | CANCIDAS |
| Common or Proper name | caspofungin for injection (as caspofungin acetate) |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CASPOFUNGIN |
| Strength(s) | 70MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10x |
| ATC code | J02AX |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-05-15 |
| Actual discontinuation date | |
| Remaining supply date | 2026-05-15 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-12-02 | French | Compare |
| v1 | 2025-12-02 | English | Compare |
Showing 1 to 2 of 2